Search

Enter keywords, a title or a report id number below.

Order by Fax Ask a Question Printer Friendly PDF Brochure

Electronic (PDF)

Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the title.

EURO€ 384.00USD$ 500.00GBP£ 323.00AUD$ 489.00JPY¥ 49,366.00SEK 3 283,00CHF 471.00CAD$ 509.00
Site License

Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access the title.

EURO€ 769.00USD$ 1,000.00GBP£ 647.00AUD$ 978.00JPY¥ 98,733.00SEK 6 566,00CHF 943.00CAD$ 1,019.00
Enterprisewide

Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access the title.

EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00

Live Chat Live Help Software for Website

Renovo Group Plc - Product Pipeline Review - H2 2011

Global Markets Direct, December 2011, Pages: 39

Renovo Group Plc – Product Pipeline Review – H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Renovo Group Plc - Product Pipeline Review - H2 2011” provides data on the Renovo Group Plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Renovo Group Plc’s corporate website, SEC filings, investor presentations and featured press releases, both from Renovo Group Plc and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Renovo Group Plc - Brief Renovo Group Plc overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Renovo Group Plc human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage

List of Tables
List of Figures
Renovo Group Plc Snapshot
Renovo Group Plc Overview
Key Information
Key Facts
Renovo Group Plc – Research and Development Overview
Key Therapeutic Areas
Renovo Group Plc – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Renovo Group Plc – Pipeline Products Glance
Renovo Group Plc – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Renovo Group Plc Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Renovo Group Plc – Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Renovo Group Plc – Drug Profiles
Juvidex
Product Description
Mechanism of Action
R&D Progress
Juvista
Product Description
Mechanism of Action
R&D Progress
Prevascar
Product Description
Mechanism of Action
R&D Progress
RN1005
Product Description
Mechanism of Action

Customers who bought this item also bought

Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network

Viewing report

• ORDER BY FAX

• REGISTER

• SELECT SITE CURRENCY

Renovo Group Plc - Product Pipeline Review - H2 2011

Global Markets Direct, December 2011, Pages: 39

Customers who bought this item also bought

For enquiries please call us on: